Showing results (51-60 of 89) with videos related to
Sort By:
Pageof 9
JAMA|May 18, 2000
Patient characteristics and ICU organizational factors that influence frequency of pulmonary artery catheterizationJ Rapoport, D Teres, J Steingrub, et al.American Journal of Industrial Medicine|January 1, 1984
Cancer mortality among workers exposed to formaldehydeT Liebling, K D Rosenman, H Pastides, et al.The Journal of Thoracic and Cardiovascular Surgery|October 1, 1983
Mechanism of plasma catecholamine increases during coronary artery bypass and valve proceduresR M Engelman, B Haag, S Lemeshow, et al.Medical Care|February 1, 1984
Two-year outcome of adult intensive care patientsJ R Parno, D Teres, S Lemeshow, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2015
Use of antihypertensive drugs and risk of skin cancerS A J Schmidt, M Schmidt, F Mehnert, et al.Archives of Internal Medicine|November 1, 1986
Enhanced bleeding with cefoxitin or moxalactam. Statistical analysis within a defined population of 1493 patientsR B Brown, J Klar, S Lemeshow, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|August 24, 1999
European system for cardiac operative risk evaluation (EuroSCORE)S A Nashef, F Roques, P Michel, et al.Medicina Clinica|April 20, 1996
[Use of mortality probability models (MPM II) in the evaluation of the effectiveness of care of critically ill patients. European and North American Study of Severity Systems]M Rué Monné, S Lemeshow, A Artigas Raventós, et al.JAMA|November 24, 1993
Mortality Probability Models (MPM II) based on an international cohort of intensive care unit patientsS Lemeshow, D Teres, J Klar, et al.Critical Care Medicine|January 1, 1996
Factors affecting the performance of the models in the Mortality Probability Model II system and strategies of customization: a simulation studyB P Zhu, S Lemeshow, D W Hosmer, et al.Pageof 9